INICIO
QUIÉNES SOMOS
ÁREA PERSONAL
INICIO
QUIÉNES SOMOS
ÁREA PERSONAL
Login
Módulo 3
Página Principal
Cursos
Diploma de Experto en Medicina Personalizada y de Precisión
M3 2025
UD2. Biología y patología molecular en enfermedades neurodegenerativas
Imaging insights into basal ganglia function, Parkinson’s disease, and dystonia
Salta al contenido principal
Imaging insights into basal ganglia function, Parkinson’s disease, and dystonia
Haga clic en
PIIS0140673614600416.pdf
para ver el archivo.
◄ Pharmacogenetics of Parkinson’s Disease in Clinical Practice
Ir a...
Ir a...
Condiciones de participación y certificación
Foro General
Parkinson’s disease
A biological classification of Parkinson’s disease: the SynNeurGe research diagnostic criteria
Pharmacogenetics of Parkinson’s Disease in Clinical Practice
Initiation of pharmacological therapy in Parkinson’s disease: when, why, and how
Biomarkers of Parkinson’s disease: 20 years later
A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research
especialNuevos tratamientos en la enfermedad de Alzheimer. New treatments in Alzheimer’s disease
2024 Alzheimer’s disease facts and figures
Genetic Testing in Epilepsy: Improving Outcomes and Informing Gaps in Research
Immune Mechanism of Epileptogenesis and Related Therapeutic Strategies
Gene-based therapies for neuromuscular disorders
Editorial: Personalized medicine for neuromuscular disorders
Neurofilaments as biomarkers in neurological disorders — towards clinical application
Oral-gut microbiome interactions in advanced cirrhosis: characterisation of pathogenic enterotypes and salivatypes, virulence factors and antimicrobial resistance
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity
Pablo Mir
3.2. Cuestinario de conocimientos adquiridos
Initiation of pharmacological therapy in Parkinson’s disease: when, why, and how ►
Copyright © Consejería de Salud y Consumo - Junta de Andalucía. Todos los derechos reservados.
